Congenital Muscular Dystrophy Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting congenital muscular dystrophy clinical trials across 12 countries. Studies span Not Applicable. Top locations include Barcelona, Barcelona, Spain, Basel, Switzerland, Bellinzona, Canton Ticino, Switzerland. Updated daily from ClinicalTrials.gov.


Congenital Muscular Dystrophy Trials at a Glance

8 actively recruiting trials for congenital muscular dystrophy are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Barcelona, Basel, and Bellinzona. Lead sponsors running congenital muscular dystrophy studies include Cure CMD, Hospital Universitari Vall d'Hebron Research Institute, and Centre Hospitalier Universitaire de Liege.

Browse congenital muscular dystrophy trials by phase

About Congenital Muscular Dystrophy Clinical Trials

Looking for clinical trials for Congenital Muscular Dystrophy? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Congenital Muscular Dystrophy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Congenital Muscular Dystrophy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Nationwide Children's Hospital44 enrolled14 locationsNCT06503367
Recruiting
Not Applicable

Modifying Factors in Striated Muscle Laminopathies

LaminopathiesEmery Dreifuss Muscular Dystrophy 2LMNA-Related Congenital Muscular Dystrophy+1 more
Institut National de la Santé Et de la Recherche Médicale, France40 enrolled8 locationsNCT05394506
Recruiting

Swiss Registry for Neuromuscular Disorders

DMDSMABMD+2 more
University of Bern2,000 enrolled19 locationsNCT05102916
Recruiting

Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers

LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)Merosin Deficient CMD (Full or Partial)Merosin Deficient Congenital Muscular Dystrophy
Università Vita-Salute San Raffaele45 enrolled1 locationNCT07125040
Recruiting
Not Applicable

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

Duchenne Muscular DystrophyFascioscapulohumeral Muscular DystrophyCentronuclear Myopathy+3 more
Centre Hospitalier Universitaire de Liege300 enrolled8 locationsNCT05982119
Recruiting

Spanish Natural History Study for LAMA2 Muscular Dystrophy

Cohort StudiesMuscular DystrophiesLAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)+2 more
Hospital Universitari Vall d'Hebron Research Institute100 enrolled1 locationNCT06924125
Recruiting

Natural History Study of Children With LAMA2-related Dystrophies

Merosin Deficient Congenital Muscular Dystrophy
Institut de Myologie, France40 enrolled4 locationsNCT06354790
Recruiting

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Limb Girdle Muscular DystrophyCongenital Myasthenic SyndromeCongenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency+48 more
Cure CMD4,000 enrolled1 locationNCT01403402